-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A breakthrough for patients: Complement inhibition in Cold Agglutinin Disease

Sponsor: Sanofi
Program: Product Theaters
Monday, December 12, 2022: 8:00 AM-9:00 AM
Hall J - Theater 6 (Ernest N. Morial Convention Center)
Matias Cordoba, MD, Sanofi Genzyme
No relevant conflicts of interest to declare.
This presentation is intended for U.S. based registered meeting attendees
See more of: Product Theaters